Unichem Laboratories Limited (NSE: UNICHEMLAB) submitted its financial results for the quarter and year ended March 31, 2026, to the exchange on May 22, 2026, following a board meeting held the same day. The announcement did not include any dividend declaration, extending what is now a six-year gap since the company last rewarded shareholders with a payout in June 2020.

No Dividend Declared for FY26

The board meeting outcome filed at 16:44 IST on May 22, 2026, covered only the financial results for the period ended March 31, 2026. No interim or final dividend was recommended alongside the results. The last dividend paid by the company was ₹4 per equity share declared on June 19, 2020, for FY20. At the current market price of ₹372.60, that historical payout would have translated to a dividend yield of approximately 1.07%, a modest return by any measure.

Dividend History Reveals a Declining and Interrupted Trend

Unichem Laboratories had maintained a reasonably consistent dividend track record through much of the previous decade, but the trend shows a clear deterioration in payout regularity and size:

The pattern indicates that peak payouts were concentrated around FY13 to FY18, after which dividend amounts declined sharply. Since FY20, no dividend has been declared across FY21, FY22, FY23, FY24, FY25, and now FY26, a continuous six-year absence that marks a significant shift in capital allocation policy.

Valuation and Market Context

Unichem Laboratories currently trades at ₹372.60, reflecting a price-to-earnings ratio of 8.77x. This stands in sharp contrast to the sector PE of 31.65x, suggesting the stock is priced at a steep discount to its pharmaceutical peers. While this gap could reflect specific operational or profitability concerns at the company level, it also places the stock among the most inexpensively valued names in the broader pharma space on a reported earnings basis.

The stock's 52-week range spans from a low of ₹278.20 recorded on March 30, 2026, to a high of ₹668.00 reached on May 22, 2025. The current price of ₹372.60 sits closer to the lower end of this range, approximately 44% below its 52-week peak and about 34% above its 52-week trough.

Trading Activity and Delivery Data

On May 22, 2026, UNICHEMLAB recorded a trading volume of 41,152 shares with a delivery percentage of 48.11%. A delivery ratio near 50% indicates that roughly half of the day's traded volume resulted in actual share transfers rather than intraday squaring off, pointing to a moderate level of positional interest among participants. Daily volatility stands at 2.44%, and the stock closed with a gain of ₹5.45 or 1.48% on the day. The company's market capitalisation stands at ₹2,623.32 Cr.

What Investors Should Note

For income-focused investors, Unichem Laboratories offers no dividend yield at present, given the unbroken six-year payout drought. The absence of a dividend recommendation alongside the FY26 results reinforces that shareholder distribution is not a near-term priority for management. Investors tracking the stock will need to assess the published financial results in detail to evaluate whether profitability metrics justify the significant valuation discount to sector peers.